![](https://www.diabetesnews.com/wp-content/uploads/2012/12/6910-150x150.jpg)
The Fridley-based medical technology giant said the Sentrino system — the first minimally invasive continuous glucose monitoring system designed for use in hospital critical care units — received CE Mark approval, meaning the system is now available for sale in Europe.
Read more